BioSpace News Archive

Modular Bioscience, an early stage biotechnology company based in Silicon Valley, announced that it has executed a definitive agreement with the University of Illinois at Urbana-Champaign for an exclusive global patent license to a novel artificial restriction enzyme platform.

CE-IVD marked molecular diagnostic tests on the Novodiag® and Amplidiag® platforms for rapid detection of COVID-19 infections to support decisions for efficient patient isolation, treatment and release

With Health Canada and the Food and Drug Administration beginning to approve and reimburse cell and gene therapies in significant numbers, the demand for cell and viral vector manufacturing will continue to grow.

Nordic Nanovector ASA announces that members of its management team will present at Jefferies Virtual Healthcare Conference, taking place 2-4 June 2020.

Corporate satellite presentation and scientific posters highlight new AmplideX® testing kits

Livongo Health, Inc. (“Livongo”) (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the pricing of $475.0 million aggregate principal amount of 0.875% convertible senior notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities

The fully enrolled placebo-controlled Phase 3 trial is evaluating NurOwn® investigational treatment in ALS patients

Pfizer Breakthrough Growth Initiative will invest up to $500 million across a portfolio of clinical-stage biotechnology companies

Bionomics Limited, a clinical stage biopharmaceutical company, announced that it has entered into a Subscription Agreement, with Apeiron Investment Group Ltd, the family office of entrepreneur and founder Christian Angermayer with a strong focus, amongst others, on life sciences, to recapitalise the Company and to assist in securing further equity capital.

Sensor Electronic Technology, Inc., the World’s first compound semiconductor for UV LED solutions and Seoul Viosys ’ subsidiary, announced that it launches portable air purifiers of brand “VAC” and surface disinfection devices of brand “VSM+” with Violeds technology to reduce infection from various harmful bacteria including new coronavirus.